AS1938909 is a SHIP2 inhibitor. It acts by increasing Akt phosphorylation, glucose consumption, and glucose uptake in L6 myotubes, specifically upregulating the GLUT1 gene. References: Suwa A, Kurama T, Yamamoto T, Sawada A, Shimokawa T, Aramori I. Glucose metabolism activation by SHIP2 inhibitors via up-regulation of GLUT1 gene in L6 myotubes. Eur J Pharmacol. 2010 Sep 10;642(1-3):177-82. doi: 10.1016/j.ejphar.2010.06.002. Epub 2010 Jun 17. PubMed PMID: 20558154.

纯度：≥98%

CAS：1243155-40-9